53 results
Type of content
News Remove News filter
Patient safety
Yes Remove Yes filter
-
List item
News: EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
CHMP, Last updated: 13/01/2023 -
List item
Press release: EMA restricts use of prostate cancer medicine Xofigo
CHMP, Last updated: 27/07/2018 -
List item
Press release: Esmya: new measures to minimise risk of rare but serious liver injury
CHMP, Last updated: 01/06/2018 -
List item
Press release: Updated measures for pregnancy prevention during retinoid use
CHMP, Last updated: 23/03/2018 -
List item
Press release: Defect with Buccolam oral syringes
CHMP, Last updated: 15/01/2018 -
List item
Press release: EMA concludes review of Zinbryta and confirms further restrictions to reduce risk of liver damage
CHMP, Last updated: 10/11/2017 -
List item
Press release: Direct-acting antivirals for hepatitis C: EMA confirms recommendation to screen for hepatitis B
CHMP, Last updated: 16/12/2016 -
List item
Press release: CHMP confirms recommendations for use of Zydelig
CHMP, Last updated: 22/07/2016 -
List item
Press release: EMA confirms recommendations to minimise ketoacidosis risk with SGLT2 inhibitors for diabetes
CHMP, Last updated: 26/02/2016 -
List item
Press release: EMA confirms recommendations to minimise risk of brain infection PML with Tysabri
CHMP, Last updated: 26/02/2016 -
List item
Press release: EMA recommends avoidance of certain hepatitis C medicines and amiodarone together
CHMP, Last updated: 24/04/2015 -
List item
Press release: GVK Biosciences: European Medicines Agency recommends suspending medicines over flawed studies
CHMP, Last updated: 23/01/2015 -
List item
Press release: European Medicines Agency recommends measures to reduce risk of heart problems with Corlentor/Procoralan (ivabradine)
CHMP, Last updated: 21/11/2014 -
List item
Press release: European Medicines Agency completes review of polymyxin-based medicines
CHMP, Last updated: 24/10/2014 -
List item
Press release: EMA confirms positive benefit-risk for antidepressant Valdoxan/Thymanax (agomelatine)
CHMP, Last updated: 26/09/2014 -
List item
Press release: Combined use of medicines affecting the renin-angiotensin system (RAS) to be restricted – CHMP endorses PRAC recommendation
CHMP, Last updated: 23/05/2014 -
List item
Press release: European Medicines Agency recommends revoking authorisations of Caustinerf arsenical and Yranicid arsenical used in dental procedures
CHMP, Last updated: 25/04/2014 -
List item
Press release: European Medicines Agency recommends that Protelos/Osseor remain available but with further restrictions
CHMP, Last updated: 21/02/2014 -
List item
Press release: Benefits of combined hormonal contraceptives (CHCs) continue to outweigh risks – CHMP endorses PRAC recommendation
CHMP, Last updated: 22/11/2013 -
List item
Press release: European Medicines Agency recommends restricting use of thiocolchicoside by mouth or injection
CHMP, Last updated: 22/11/2013 -
List item
Press release: European Medicines Agency recommends changes in use of leukaemia medicine Iclusig (ponatinib) in order to minimise risk of blood clots
CHMP, Last updated: 22/11/2013 -
List item
Press release: European Medicines Agency recommends changes to the use of metoclopramide
CHMP, Last updated: 26/07/2013 -
List item
Press release: European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole
CHMP, Last updated: 26/07/2013 -
List item
Press release: New recommendations to manage risk of allergic reactions with intravenous iron-containing medicines
CHMP, Last updated: 28/06/2013 -
List item
Press release: New restrictions on use of medicines containing ergot derivatives
CHMP, Last updated: 28/06/2013